G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

G&E Herbal Biotechnology Revenue

G&E Herbal Biotechnology had revenue of 79.78M TWD in the quarter ending September 30, 2025, with 33.96% growth. This brings the company's revenue in the last twelve months to 311.78M, up 37.92% year-over-year. In the year 2024, G&E Herbal Biotechnology had annual revenue of 249.03M with 37.25% growth.

• Revenue (ttm): 311.78M
• Revenue Growth: +37.92%
• P/S Ratio: 9.76
• Revenue / Employee: 7.99M
• Employees: 39
• Market Cap: 3.04B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	249.03M	67.59M	37.25%
Dec 31, 2023	181.44M	116.84M	180.84%
Dec 31, 2022	64.61M	40.04M	162.94%
Dec 31, 2021	24.57M	-3.66M	-12.96%
Dec 31, 2020	28.23M	10.68M	60.82%